Moderna (MRNA) Stock: Buy, Sell, or Hold?
MRNA - Moderna, Inc. Common Stock
$145.62
1.85 (1.29%)
â˛
5d:
+7.38%
30d:
+125.91%
90d:
+162.85%
WAIT
LOW Confidence
Analysis Updated: Sep 16, 2026 12:00 AM ET
Earnings: Nov 05, 2026
Smart Money Accumulation
Options open interest is building while the stock consolidates - a pattern consistent with institutional accumulation. View Scanner →
Signal fired Sep 1, 2026 at $148.71 · last confirmed Sep 15, 2026
Strength: 9.0/10
Get Alerted When MRNA Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: MRNA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: MRNA is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: MRNA is currently trading at $145.62, which is considered slightly high relative to its 30-day fair value range of $86.92 to $161.37.
Technical Outlook: Technically, MRNA is in a strong uptrend. Immediate support is located at $130.38, while resistance sits at $156.42.
Market Sentiment: MRNA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $119.56. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MRNA is in a strong uptrend. Immediate support is located at $130.38, while resistance sits at $156.42.
Market Sentiment: MRNA scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $119.56. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$86.92 -
$161.37
Company Quality Score
43/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
31.6%
Protect Your Profits
Holding MRNA? Use our AI-powered strategies to protect your downside while keeping your long-term position.
View Profit Protection PlanAll Signals
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BEARISH: Trading 17.9% above Wall St target ($119.56)
- WARNING: Composite score 43/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$86.92 -
$161.37
Current vs Trading Range
SLIGHTLY HIGH
Support & Resistance Levels
Support Level
$130.38
Resistance Level
$156.42
Current Trend
Strong Uptrend
Technical data as of
Sep 16, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-30.42
Wall Street Target
$119.56
(-17.9%)
Revenue Growth (YoY)
2.1%
Earnings Growth (YoY)
-85.1%
Profit Margin
-141.4%
Share & Embed Analysis
Last updated: September 17, 2026 12:45 AM ET
Data refreshes hourly during market hours. Next update: 1:45 AM
Data refreshes hourly during market hours. Next update: 1:45 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MRNA showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ONC
BeiGene, Ltd. |
STRONG BUY
24 analysts |
$432 | 62 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$88 | 59 HOLD |
|
INSM
Insmed Inc |
STRONG BUY
21 analysts |
$200 | 51 HOLD |
|
CYTK
Cytokinetics Inc |
STRONG BUY
21 analysts |
$110 | 55 HOLD |
|
CRNX
Crinetics PharmaceuticalâĻ |
STRONG BUY
17 analysts |
$86 | 46 HOLD |
Advanced MRNA Option Strategies
Professional options setups generated by AI based on today's MRNA price and gamma walls.
